Last reviewed · How we verify

intermittent fentanyl infusion

Kaohsiung Veterans General Hospital. · FDA-approved active Small molecule

Intermittent fentanyl infusion delivers the opioid fentanyl in periodic doses to provide pain relief while potentially reducing continuous exposure.

Intermittent fentanyl infusion delivers the opioid fentanyl in periodic doses to provide pain relief while potentially reducing continuous exposure. Used for Acute postoperative pain, Acute pain in hospitalized patients.

At a glance

Generic nameintermittent fentanyl infusion
SponsorKaohsiung Veterans General Hospital.
Drug classOpioid agonist
TargetMu-opioid receptor (OPRM1)
ModalitySmall molecule
Therapeutic areaPain management
PhaseFDA-approved

Mechanism of action

Fentanyl is a potent synthetic opioid agonist that binds to mu-opioid receptors in the central and peripheral nervous system to modulate pain perception and transmission. Intermittent infusion (as opposed to continuous infusion) administers fentanyl in scheduled intervals, which may help balance analgesia with reduced side effects from sustained high drug levels. This dosing approach is typically used in acute or perioperative pain management settings.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results